{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:50:50Z","timestamp":1791399050349,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.cjca.2010.12.040","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T19:51:46Z","timestamp":1301687506000},"page":"174-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review"],"prefix":"10.1016","volume":"27","author":[{"given":"Idan","family":"Roifman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2010.12.040_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib2","first-page":"190","article-title":"Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart Association","volume":"54","author":"Eyre","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cjca.2010.12.040_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2010.12.040_bib4","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","article-title":"Inflammation and cardiovascular disease mechanisms","volume":"83","author":"Libby","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cjca.2010.12.040_bib5","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib7","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/01.ATV.0000171992.36710.1e","article-title":"No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden\/human C-reactive protein transgenic mice","volume":"25","author":"Trion","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2010.12.040_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2007.05.010","article-title":"Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-\/- mice","volume":"196","author":"Tennent","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2010.12.040_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3181\/0812-RM-347","article-title":"Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice","volume":"234","author":"Ortiz","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.cjca.2010.12.040_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1160\/TH07-10-0595","article-title":"No effect of C-reactive protein on early atherosclerosis in LDLR-\/- human C-reactive protein transgenic mice","volume":"99","author":"Torzewski","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2010.12.040_bib11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00365510903056015","article-title":"C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease","volume":"69","author":"Zacho","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cjca.2010.12.040_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/41.10.1095","article-title":"Long-term complications of systemic lupus erythematosus","volume":"41","author":"Gordon","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cjca.2010.12.040_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rdc.2005.11.003","article-title":"Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents","volume":"32","author":"Dooley","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.cjca.2010.12.040_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/08916930500285857","article-title":"Drug-induced lupus erythematosus","volume":"38","author":"Sarzi-Puttini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cjca.2010.12.040_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2010.12.040_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib18","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2010.12.040_bib19","first-page":"f36","article-title":"Rheumatoid arthritis and heart disease","volume":"113","author":"Nicholls","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib20","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cjca.2010.12.040_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2010.12.040_bib22","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib23","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rincon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2010.12.040_bib24","doi-asserted-by":"crossref","first-page":"R984","DOI":"10.1186\/ar1775","article-title":"Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study","volume":"7","author":"Warrington","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cjca.2010.12.040_bib25","first-page":"958","article-title":"National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study","volume":"30","author":"Thomas","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cjca.2010.12.040_bib26","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.10419","article-title":"Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients","volume":"46","author":"Goodson","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2010.12.040_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cjca.2010.12.040_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cjca.2010.12.040_bib29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1572-0241.2006.01018.x","article-title":"Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis","volume":"102","author":"Dorn","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cjca.2010.12.040_bib30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3899\/jrheum.090061","article-title":"Arterial events in persons with dermatomyositis and polymyositis","volume":"36","author":"Tisseverasinghe","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cjca.2010.12.040_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis (PsA)","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2010.12.040_bib32","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","article-title":"New markers of inflammation and endothelial cell activation: part I","volume":"108","author":"Szmitko","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"Fundamentals of endothelial function for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib34","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000089191.72957.ED","article-title":"Endothelial function testing as a biomarker of vascular disease","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib35","first-page":"1335","article-title":"Endothelial function: ready for prime time?","volume":"20","author":"Verma","year":"2004","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib37","doi-asserted-by":"crossref","first-page":"23F","DOI":"10.1016\/j.amjcard.2008.04.015","article-title":"Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention","volume":"101","author":"Anderson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib38","first-page":"221","article-title":"Atherosclerosis: an inflammatory disease","volume":"26","author":"Liuzzo","year":"2001","journal-title":"Rays"},{"key":"10.1016\/j.cjca.2010.12.040_bib39","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1161\/01.CIR.0000065232.57371.25","article-title":"Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes","volume":"107","author":"Heeschen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9149(01)02190-7","article-title":"Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction","volume":"89","author":"Zebrack","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0735-1097(01)01804-6","article-title":"C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina","volume":"39","author":"Zebrack","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib43","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis","volume":"35","author":"Heeschen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2010.12.040_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib45","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease","volume":"96","author":"Toss","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2010.12.040_bib47","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.0000017493.03108.1C","article-title":"Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death","volume":"105","author":"Albert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2010.12.040_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X10000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X10000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:35:42Z","timestamp":1760106942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X10000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0828282X10000565"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.040","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Inflammatory Diseases and Cardiovascular Risk: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2010.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}